BridgeBio
Venture Capital
Publicly traded biotechnology company developing medicines for genetic diseases; invests in pipeline subsidiaries.
San Francisco, United States · 3+ investments
Growth
Late Stage
Biotech
Genetic Medicine
Healthcare
- Headquarters
- San Francisco, United States
- Founded
- 2015
- Website
- bridgebio.com
- Total Investments
- 3
- Last Investment
- Jan 2021
- Geographic Focus
- United States
Investment Thesis
Build and fund genetically-validated drug programs using portfolio theory to diversify pipeline risk across rare genetic diseases.
BridgeBio is a Venture Capital firm based in San Francisco, United States. It has made 3 investments in Biotech and Genetic Medicine.
Investment History
Sign up to view investment history
Create a free account — 25 credits a month to unlock deal history, amounts, and round details.